Zulilig Pharma在韩国开通了3 800平方米临床试验中心, Zuellig Pharma opens a 3,800-square-meter clinical trial center in South Korea to boost global research logistics and treatment access.

Zulilig Pharma在韩国庆吉岛开设了一个新的临床试验支助创新中心,这是一个3 800平方米的设施,目的是通过自动化操作、安全跟踪和专门储存温度敏感疗法,推进临床试验后勤。 Zuellig Pharma has opened a new Clinical Trial Support Innovation Center in Gyeonggi-do, South Korea, a 3,800-square-meter facility designed to advance clinical trial logistics with automated operations, secure tracking, and specialized storage for temperature-sensitive therapies. 该中心支持全球和国内研究,处理生物病理学、基因治疗和医疗设备,并完全符合GxP标准。 The center supports global and domestic research, handling biologics, gene treatments, and medical devices with full compliance to GxP standards. 它已为3 000多份研究报告和100名客户提供服务,包括主要制药公司和临床研究组织,每年管理约13 000批货物。 It has already served over 3,000 studies and 100 clients, including major pharmaceutical firms and clinical research organizations, managing around 13,000 shipments annually. 这一发展加强了韩国在全球临床研究中的作用,并增进了亚洲各地获得创新治疗的机会。 The development strengthens South Korea’s role in global clinical research and enhances access to innovative treatments across Asia.